Grace Therapeutics, Inc. (GRCE)

Grace Therapeutics Statistics

Total Valuation

GRCE has a market cap or net worth of $38.73 million. The enterprise value is $23.56 million.

Market Cap	38.73M
Enterprise Value	23.56M

Important Dates

The next estimated earnings date is Tuesday, December 31, 2024, before market open.

Earnings Date	Dec 31, 2024
Ex-Dividend Date	n/a

Share Statistics

GRCE has 10.14 million shares outstanding. The number of shares has increased by 54.23% in one year.

Current Share Class	10.14M
Shares Outstanding	10.14M
Shares Change (YoY)	+54.23%
Shares Change (QoQ)	+5.29%
Owned by Insiders (%)	27.98%
Owned by Institutions (%)	7.37%
Float	4.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.69
P/TBV Ratio	5.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.01

Current Ratio	6.01
Quick Ratio	5.83
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -18.89% and return on invested capital (ROIC) is -16.28%.

Return on Equity (ROE)	-18.89%
Return on Assets (ROA)	-13.94%
Return on Capital (ROIC)	-16.28%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-2.67M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	1.48
52-Week Price Change	n/a
50-Day Moving Average	3.44
200-Day Moving Average	n/a
Relative Strength Index (RSI)	53.31
Average Volume (20 Days)	76,855

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-16.01M
Pretax Income	n/a
Net Income	-11.61M
EBITDA	-16.00M
EBIT	-16.01M
Earnings Per Share (EPS)	-$1.01

Balance Sheet

Cash & Cash Equivalents	15.17M
Total Debt	n/a
Net Cash	15.17M
Net Cash Per Share	$1.50
Equity (Book Value)	56.13M
Book Value Per Share	5.54
Working Capital	13.39M

Cash Flow

In the last 12 months, operating cash flow was -$11.82 million and capital expenditures -$22,000, giving a free cash flow of -$11.84 million.

Operating Cash Flow	-11.82M
Capital Expenditures	-22,000
Free Cash Flow	-11.84M
FCF Per Share	-$1.17

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GRCE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-54.23%
Shareholder Yield	-54.23%
Earnings Yield	-29.96%
FCF Yield	-30.56%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on July 10, 2023. It was a reverse split with a ratio of 0.1666667:1.

Last Split Date	Jul 10, 2023
Split Type	Reverse
Split Ratio	0.1666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a